This review suggests that polymorphism within ACE, AKR1B1, APOE, MTHFR, NOS3, and VEGF may act as common genetic risk factors for the diabetic neuropathies in T2DM (Figure 2). The gene discussed is VEGFA; the disease is type 2 diabetes mellitus.